Related Experiment Video

Updated: Jul 8, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
05:53

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates

Published on: July 6, 2013

Indirect effects of cytomegalovirus infection in solid organ transplant recipients

María José Pérez-Sola1, Juan José Castón, Rafael Solana

  • 1Clinic Unit of Infectious Diseases, Reina Sofia University Hospital, Córdoba, Spain.

Enfermedades Infecciosas Y Microbiologia Clinica
|January 23, 2008
PubMed

Insights

Cytomegalovirus (CMV) infection poses risks for solid organ transplant (SOT) recipients. Universal prophylaxis effectively prevents CMV disease and its severe indirect effects, such as graft rejection.

Area of Science:

  • Immunology
  • Virology
  • Transplant Medicine

Background:

  • Cytomegalovirus (CMV) infection is a common and significant complication in solid organ transplant (SOT) recipients.
  • CMV infection can cause direct cellular damage and indirect immune-mediated effects, including graft rejection and increased susceptibility to other infections.
  • These indirect effects can severely impact patient survival and graft outcomes.

Purpose of the Study:

  • To review the impact of Cytomegalovirus (CMV) infection in solid organ transplant (SOT) recipients.
  • To highlight the direct and indirect effects of CMV infection.
  • To emphasize the importance of preventative strategies against CMV in SOT patients.

Main Methods:

  • Review of existing literature on Cytomegalovirus (CMV) infection in solid organ transplant (SOT) recipients.
  • Analysis of the direct and indirect mechanisms of CMV pathogenesis.
  • Evaluation of the efficacy of preventative practice guidelines.

Main Results:

  • CMV infection leads to direct viral damage and indirect immune responses.
  • Indirect effects include increased graft rejection, opportunistic infections, and reduced recipient survival.
  • Universal prophylaxis has demonstrated effectiveness in preventing CMV disease and asymptomatic replication.

Conclusions:

  • Universal prophylaxis is a crucial strategy for managing Cytomegalovirus (CMV) in solid organ transplant (SOT) recipients.
  • Preventing CMV disease and its indirect effects is essential for improving patient and graft outcomes.
  • Prophylactic measures should be considered the standard of care for CMV prevention in SOT.

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...